Abstract Drew Pardoll (Johns Hopkins Oncology Center) examines prospects for therapeutic
cancer vaccines. Considering how it is that the immune system fails to recognize and …

Systematic, centrally analysed data on cancer survival from 10 population-based cancer
registries in 5 developing countries (China, India, Cuba, Philippines and Thailand) are …

A retrospective case-control study was conducted to determine why some infants born full-
term without obstetric intervention to hepatitis B e antigen (HBeAg)-seropositive mothers …

In the relatively brief history of cancer chemoprevention, hundreds of chemoprevention
studies have been reported. The vast majority were uncontrolled studies that were designed …

Hepatocellular carcinoma (HCC) is one of the major causes of human cancer deaths
worldwide. To identify alterations of the genetic program associated with human HCC, we …

Powerful diagnostic technology, plus the realization that organisms of otherwise
unimpressive virulence can produce slowly progressive chronic disease with a wide …

In addition to causing acute and chronic hepatitis, hepatitis B virus (HBV) is considered to be
a major cliological factor in the development of human hepatocellular carcinoma (HCC) …

More than 90 countries have now included hepatitis B (HB) immunization into their National
Immunization Programmes as a routine vaccine given to all infants and/or adolescents and …

Hepatitis B virus (HBV) is one of the world's most widespread infectious agents and the
cause of millions of diseases and deaths each year. Vaccination programmes aimed at risk …

Hepatitis B virus (HBV) is a small, enveloped DNA virus which primarily infects liver cells
and causes acute and persistent liver disease. Chronic HBV infection, frequently associated …